Home688062 • SHA
add
Mabwell Shanghai Bioscience Co Ltd
Previous close
¥18.15
Day range
¥17.98 - ¥18.78
Year range
¥15.36 - ¥37.00
Market cap
6.24B CNY
Avg Volume
5.63M
P/E ratio
-
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 57.69M | 103.68% |
Operating expense | 455.95M | 11.94% |
Net income | -372.83M | 1.92% |
Net profit margin | -646.26 | 51.85% |
Earnings per share | — | — |
EBITDA | -373.01M | 0.49% |
Effective tax rate | 1.36% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.59B | -6.80% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 1.90B | — |
Shares outstanding | 399.60M | — |
Price to book | 3.78 | — |
Return on assets | — | — |
Return on capital | -23.71% | — |
Cash Flow
Net change in cash
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -372.83M | 1.92% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
May 12, 2017
Website
Employees
1,402